423 related articles for article (PubMed ID: 17467628)
1. Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
Lehtonen A; Fodstad H; Laitinen-Forsblom P; Toivonen L; Kontula K; Swan H
Heart Rhythm; 2007 May; 4(5):603-7. PubMed ID: 17467628
[TBL] [Abstract][Full Text] [Related]
2. Genetic modulation of cardiac repolarization reserve.
Remme CA; Bezzina CR
Heart Rhythm; 2007 May; 4(5):608-10. PubMed ID: 17467629
[No Abstract] [Full Text] [Related]
3. Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients.
Fodstad H; Bendahhou S; Rougier JS; Laitinen-Forsblom PJ; Barhanin J; Abriel H; Schild L; Kontula K; Swan H
Ann Med; 2006; 38(4):294-304. PubMed ID: 16754261
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ventricular pacing in the treatment of an arrhythmic storm associated with a congenital long QT mutation.
Aziz PF; Shah MJ
Congenit Heart Dis; 2013; 8(6):E165-7. PubMed ID: 23075154
[TBL] [Abstract][Full Text] [Related]
5. Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland.
Fodstad H; Swan H; Laitinen P; Piippo K; Paavonen K; Viitasalo M; Toivonen L; Kontula K
Ann Med; 2004; 36 Suppl 1():53-63. PubMed ID: 15176425
[TBL] [Abstract][Full Text] [Related]
6. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of four long QT syndrome founder mutations in the Finnish population.
Marjamaa A; Salomaa V; Newton-Cheh C; Porthan K; Reunanen A; Karanko H; Jula A; Lahermo P; Väänänen H; Toivonen L; Swan H; Viitasalo M; Nieminen MS; Peltonen L; Oikarinen L; Palotie A; Kontula K
Ann Med; 2009; 41(3):234-40. PubMed ID: 19160088
[TBL] [Abstract][Full Text] [Related]
8. Atrioventricular block-induced Torsades de Pointes with clinical and molecular backgrounds similar to congenital long QT syndrome.
Oka Y; Itoh H; Ding WG; Shimizu W; Makiyama T; Ohno S; Nishio Y; Sakaguchi T; Miyamoto A; Kawamura M; Matsuura H; Horie M
Circ J; 2010 Nov; 74(12):2562-71. PubMed ID: 20975234
[TBL] [Abstract][Full Text] [Related]
9. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
Jacobson I; Carlsson L; Duker G
J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
[TBL] [Abstract][Full Text] [Related]
10. A case series of drug-induced long QT syndrome and Torsade de Pointes.
Tong KL; Lau YS; Teo WS
Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome.
Cuneo BF; Etheridge SP; Horigome H; Sallee D; Moon-Grady A; Weng HY; Ackerman MJ; Benson DW
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):946-51. PubMed ID: 23995044
[TBL] [Abstract][Full Text] [Related]
13. Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome.
Itoh H; Sakaguchi T; Ding WG; Watanabe E; Watanabe I; Nishio Y; Makiyama T; Ohno S; Akao M; Higashi Y; Zenda N; Kubota T; Mori C; Okajima K; Haruna T; Miyamoto A; Kawamura M; Ishida K; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Sugimoto Y; Ashihara T; Hayashi H; Ito M; Imoto K; Matsuura H; Horie M
Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):511-23. PubMed ID: 19843919
[TBL] [Abstract][Full Text] [Related]
14. Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome.
Grunnet M; Behr ER; Calloe K; Hofman-Bang J; Till J; Christiansen M; McKenna WJ; Olesen SP; Schmitt N
Heart Rhythm; 2005 Nov; 2(11):1238-49. PubMed ID: 16253915
[TBL] [Abstract][Full Text] [Related]
15. Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome.
Haraoka K; Morita H; Saito Y; Toh N; Miyoshi T; Nishii N; Nagase S; Nakamura K; Kohno K; Kusano KF; Kawaguchi K; Ohe T; Ito H
Heart Rhythm; 2010 Dec; 7(12):1808-14. PubMed ID: 20837161
[TBL] [Abstract][Full Text] [Related]
16. Long QT and Brugada syndrome gene mutations in New Zealand.
Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
[TBL] [Abstract][Full Text] [Related]
17. Molecular predictors of drug-induced prolongation of the QT interval.
Dilaveris PE
Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):105-18. PubMed ID: 15853698
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
Wegener FT; Ehrlich JR; Hohnloser SH
Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
[No Abstract] [Full Text] [Related]
19. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
[TBL] [Abstract][Full Text] [Related]
20. Genetics of long QT syndrome.
Tester DJ; Ackerman MJ
Methodist Debakey Cardiovasc J; 2014; 10(1):29-33. PubMed ID: 24932360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
